Ovid Therapeutics Inc. (OVID)

SEC filing

Ovid Therapeutics Inc.

OVID · CIK 1636651

4 · Apr 9, 2026 · PAPADOPOULOS STELIOS was granted 17.58K shares at $2.56/share ($45,000)

PAPADOPOULOS STELIOS was granted 17.58K shares at $2.56/share ($45,000)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.